These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 26740155)
1. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors. Wambang N; Schifano-Faux N; Aillerie A; Baldeyrou B; Jacquet C; Bal-Mahieu C; Bousquet T; Pellegrini S; Ndifon PT; Meignan S; Goossens JF; Lansiaux A; Pélinski L Bioorg Med Chem; 2016 Feb; 24(4):651-60. PubMed ID: 26740155 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 2-phenylnaphthalenoids as inhibitors of DNA topoisomeraseIIα and antitumor agents. Chen W; Shen Y; Li Z; Zhang M; Lu C; Shen Y Eur J Med Chem; 2014 Oct; 86():782-96. PubMed ID: 25240702 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors. My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives. Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and modeling studies of terphenyl topoisomerase IIα inhibitors as anticancer agents. Qiu J; Zhao B; Zhong W; Shen Y; Lin H Eur J Med Chem; 2015 Apr; 94():427-35. PubMed ID: 25800514 [TBL] [Abstract][Full Text] [Related]
8. Search for human DNA topoisomerase II poisons in the group of 2,5-disubstituted-1,3,4-thiadiazoles. Plech T; Kaproń B; Paneth A; Wujec M; Czarnomysy R; Bielawska A; Bielawski K; Trotsko N; Kuśmierz E; Paneth P J Enzyme Inhib Med Chem; 2015 Dec; 30(6):1021-6. PubMed ID: 25792499 [TBL] [Abstract][Full Text] [Related]
9. Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor. Kadayat TM; Park C; Jun KY; Thapa Magar TB; Bist G; Yoo HY; Kwon Y; Lee ES Eur J Med Chem; 2015 Jan; 90():302-14. PubMed ID: 25437617 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines. Kadayat TM; Song C; Shin S; Magar TB; Bist G; Shrestha A; Thapa P; Na Y; Kwon Y; Lee ES Bioorg Med Chem; 2015 Jul; 23(13):3499-512. PubMed ID: 26022080 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues. Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies. Arjmand F; Yousuf I; Hadda Tb; Toupet L Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives. Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368 [TBL] [Abstract][Full Text] [Related]
15. 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage. Park SE; Chang IH; Jun KY; Lee E; Lee ES; Na Y; Kwon Y Eur J Med Chem; 2013 Nov; 69():139-45. PubMed ID: 24013413 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor. Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530 [TBL] [Abstract][Full Text] [Related]
18. A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. Karki R; Jun KY; Kadayat TM; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES Eur J Med Chem; 2016 May; 113():228-45. PubMed ID: 26945111 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors. Subba Rao AV; Vishnu Vardhan MV; Subba Reddy NV; Srinivasa Reddy T; Shaik SP; Bagul C; Kamal A Bioorg Chem; 2016 Dec; 69():7-19. PubMed ID: 27656775 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors. Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]